Clinical Trial Update: Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allogeneic adipose tissue-derived mesenchymal stem cells for ischemic stroke; current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Allogeneic adipose tissue-derived mesenchymal stem cells

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Ischemic Stroke, Adipose Tissue-derived Stem Cell | Phase 2 | Status: UNKNOWN